Compare VYNE & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYNE | BATL |
|---|---|---|
| Founded | 2003 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 17.9M |
| IPO Year | 2017 | 2004 |
| Metric | VYNE | BATL |
|---|---|---|
| Price | $0.61 | $3.06 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 138.7K | ★ 10.3M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 33.33 | ★ 42.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $166,043,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.29 | $1.00 |
| 52 Week High | $1.98 | $29.70 |
| Indicator | VYNE | BATL |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 37.01 |
| Support Level | $0.56 | $2.70 |
| Resistance Level | $0.75 | $5.47 |
| Average True Range (ATR) | 0.02 | 0.60 |
| MACD | 0.00 | -0.11 |
| Stochastic Oscillator | 68.54 | 1.86 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.